Ubs Group Ag Sight Sciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,532,323 shares of SGHT stock, worth $9.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,532,323

Previous 2,855,850 11.33%

Holding current value

$9.45 Million

Previous $19 Million 16.25%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.49 - $8.31 $1.78 Million - $2.69 Million	-323,527 Reduced 11.33%	2,532,323 $16 Million
Q2 2024 Aug 13, 2024	SELL	$5.13 - $7.15 $81,638 - $113,785	-15,914 Reduced 0.55%	2,855,850 $19 Million
Q1 2024 May 13, 2024	SELL	$4.02 - $5.89 $97,259 - $142,502	-24,194 Reduced 0.84%	2,871,764 $15.2 Million
Q4 2023 Feb 09, 2024	BUY	$1.29 - $5.86 $3.72 Million - $16.9 Million	2,881,750 Added 20282.59%	2,895,958 $14.9 Million
Q3 2023 Nov 09, 2023	SELL	$2.88 - $8.8 $17,314 - $52,905	-6,012 Reduced 29.73%	14,208 $47,000
Q2 2023 Aug 11, 2023	BUY	$7.46 - $10.67 $75,413 - $107,863	10,109 Added 99.98%	20,220 $167,000
Q1 2023 May 12, 2023	BUY	$8.44 - $13.35 $35,338 - $55,896	4,187 Added 70.68%	10,111 $88,000
Q4 2022 Feb 08, 2023	SELL	$5.58 - $13.94 $104,145 - $260,176	-18,664 Reduced 75.91%	5,924 $72,000
Q3 2022 Nov 10, 2022	BUY	$6.1 - $11.41 $149,986 - $280,549	24,588 New	24,588 $156,000
Q2 2022 Aug 10, 2022	SELL	$6.61 - $11.99 $8,830 - $16,018	-1,336 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$11.56 - $17.9 $28,946 - $44,821	-2,504 Reduced 65.21%	1,336 $15,000
Q4 2021 Feb 14, 2022	BUY	$17.36 - $27.36 $66,662 - $105,062	3,840 New	3,840 $67,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

21.6M

Call Options Held

66.8K

Put Options Held

13K

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $178M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account